CSIMarket
 



Kinnate Biopharma Inc   (KNTE)
Other Ticker:  
 



Kinnate Biopharma Inc 's Debt Coverage ratios

KNTE's Debt and Ebitda growth


KNTE Debt Coverage (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Total Debt Change - - - - -
Y / Y Ebitda Change - - - - -
Debt Coverage (TTM) - - - - -
Total Ranking # # # # #
Seq. Total Debt Change - - - - -
Seq. Ebitda Change - - - - -





Debt Coverage Ratio third quarter of 2023 Comment
Company did not have debt in the third quarter of 2023.

Within Healthcare sector Kinnate Biopharma Inc achieved highest debt coverage ratio in the third quarter of 2023. While debt coverage ratio ranking remained unchanged in the Q3 2023 compared to the second quarter 2023 at no. .
Debt Coverage Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #


Debt Coverage Ratio Statistics
High Average Low
0 0 0
 



Financial Statements
Kinnate Biopharma Inc 's Total Debt $ 0 Millions Visit KNTE's Balance sheet
Kinnate Biopharma Inc 's Ebitda $ -31 Millions Visit KNTE's Income Statement
Where are KNTE's Sales coming from? Visit KNTE's Sales by Geography




Companies with similar Debt Coverage Sep 30 2023, within Healthcare Sector Debt Coverage
Date modified: 2023-11-12T10:02:19+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com